Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani

Parasitology International

Volumn 56, Issue 1, 2007, Pages 77-80

  Kothari, Hema ^a   Kumar, Pranav ^a   Sundar, Shyam ^b   Singh, Neeloo ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Clinical isolates; Drug resistance; Leishmania; Visceral leishmaniasis (VL)

Indexed keywords

ANTILEISHMANIAL AGENT; ANTIMONY DERIVATIVE;

ARTICLE; DRUG EFFECT; LEISHMANIA DONOVANI; MEMBRANE STRUCTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTOZOAL GENETICS; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIMONY; ANTIPROTOZOAL AGENTS; BLOTTING, NORTHERN; CELL MEMBRANE; DRUG RESISTANCE; GENES, PROTOZOAN; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MEMBRANE PROTEINS; PROTOZOAN PROTEINS; RNA, PROTOZOAN;

LEISHMANIA DONOVANI;

EID: 33847053556     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2006.10.005     Document Type: Article

References (24)

1. Jha T.K. Drug unresponsiveness and combination therapy for kala-azar. Indian J Med Res 123 (2006) 389-398
2. Sundar S., More D.K., Singh M.K., Singh V.P., Sharma S., Makharia A., et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of Indian epidemic. Clin Infect Dis 31 (2000) 1104-1107
3. Shaked-Mishan P., Ulrich N., Ephros M., and Zilberstein D. Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani. J Biol Chem 276 6 (2001) 3971-3976
4. Berman J.D., Gallalee J.V., and Best J.M. Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes. Biochem Pharmacol 36 (1987) 197-201
5. Sereno D., Holzmuller P., Mangot I., Cuny G., Ouaissi A., and Lemesre J.L. Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrob Agents Chemother 45 (2001) 2064-2069
6. 2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes. J Biol Chem 278 (2003) 25120-25132
7. Wyllie S., Cunningham M.L., and Fairlamb A.H. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. J Biol Chem 279 (2004) 39925-39932
8. Pathak M.K., and Yi T. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J Immunol 167 (2001) 3391-3397
9. Grondin K., Haimeur A., Mukhopadhayay R., Rosen B.P., and Ouellette M. Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentole. EMBO J 16 (1997) 3057-3065
10. Guimond C., Trudel N., Brochu C., Marquis N., El Fadili A., Peytavi R., et al. Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays. Nucleic Acids Res 31 (2003) 5886-5896
11. Haimeur A., Guimond C., Pilote S., Mukhopadhyay R., Rosen B.P., Poulin R., et al. Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania. Mol Microbiol 34 (1999) 726-735
12. El Fadili K., Messier N., Leprohon P., Roy G., Guimond C., Trudel N., et al. Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes. Antimicrob Agents Chemother 49 (2005) 1988-1993
13. Haimeur A., Brochu C., Genest P., Papadopoulou B., and Ouellette M. Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate Sb(III) resistant Leishmania tarentole. Mol Biochem Parasitol 108 (2000) 131-135
14. Gourbal B., Sonuc N., Bhattacharjee H., Legare D., Sundar S., Ouellette M., et al. Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J Biol Chem 279 (2004) 31010-31017
15. Marquis N., Gourbal B., Rosen B.P., Mukhopadhyay R., and Ouellette M. Modulation in aquaglyceroporin AQP1 gene transcript levels in drug resistant Leishmania. Mol Microbiol 57 (2005) 1690-1699
16. Singh N., Singh Ramsing Th., and Sundar S. Novel mechanism of drug resistance in kala azar field isolates. JID 188 (2003) 600-607
17. Decuypere S., Rijal S., Yardley V., De Doncker S., Laurent T., Khanal B., et al. Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob Agents Chemother 49 (2005) 4616-4621
18. Singh N. Drug resistance mechanisms in clinical isolates of Leishmania donovani. Indian J Med Res 123 (2006) 411-422
19. Singh R., Kumar D., Ramesh V., Negi N.S., Singh S., and Salotra P. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis. J Infect Dis 194 3 (2006) 302-306
20. Dube A., Singh N., Sundar S., and Singh N. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persists in in vitro and in vivo experimental models. Parasitol Res 96 (2005) 216-223
21. Kothari H., Kumar P., and Singh N. Prokaryotic expression, purification, and polyclonal antibody production against a novel drug resistance gene of Leishmania donovani clinical isolate. Protein Expr Purif 45 (2006) 15-21
22. Conseil G., Perez-Victoria J.M., Jault J.M., Gamarro F., Goffeau A., Hofmann J., et al. Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity. Biochemistry 40 (2001) 2564-2571
23. Rakotomanga M., Saint-Pierre-Chazalet M., and Loiseau P.M. Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions. Antimicrob Agents Chemother 49 (2005) 2677-2686
24. Perez-Victoria F.J., Castanys S., and Gamarro F. Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug. Antimicrob Agents Chemother 47 (2003) 2397-2403